Skip to content

Mainz Epilepsy Registry

Study on Disease Course and Quality of Life in Patients With Epilepsy (Mainz Epilepsy Registry)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05267405
Acronym
MAINZ-EPIREG
Enrollment
700
Registered
2022-03-04
Start date
2018-02-01
Completion date
2024-01-31
Last updated
2022-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dissociative Seizures, Epilepsy, Status Epilepticus

Brief summary

Prospective longitudinal observational registry study of all patients with epilepsy treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.

Detailed description

Clinical parameters of patients, such as onset of the disease, prior medication, disease severity, which are important for the data analysis also collected retrospectively before the initiation of the registry. Data on the quality of life is collected only prospectively.

Interventions

OTHERno interventions, only observation

no interventions, only observation

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Epileptic or psychogenic seizures

Exclusion criteria

* age\<18 * patients who cannot provide informed consent and don't have a legal guardian

Design outcomes

Primary

MeasureTime frameDescription
monthly seizure frequency after 6 months6 monthsmonthly seizure frequency at the follow-up after 6 months
European Quality of Life 5 dimensions Index (EQ 5D Index)6 monthshealth-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)
monthly seizure frequency after 12 months12 monthsmonthly seizure frequency at the follow-up after 12 months
Seizure freedom6 monthspercentage of patients without epileptic seizures
interruption of status epilepticus48 hourspercentage of patients with interrupted status epilepticus

Secondary

MeasureTime frameDescription
Resilience Scale 1312 monthsResilience Scale 13 (short version with 13 questions): 13-66 points correspond with low resilience, 67-72 with moderate and 73-91 with high resilience
Pittsburgh Sleep Quality Index12 monthsPittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality
Multidimensional Fatigue Inventory12 monthsMultidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue. Measures range from 0-100, representing more severe fatigue at higher scores
Beck Depression Inventory II12 monthsBeck Depression Inventory II: higher scores correspond to more severe depression (range 0-63)
Berlin Social Support Scales (BSSS)12 monthsBerlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support
World Health Organization Quality of Life-BREF (WHOQOL-BREF)12 monthsWorld Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)

Countries

Germany

Contacts

Primary ContactYaroslav Winter, MD, MSc
yaroslav.winter@unimedizin-mainz.de+496131172234

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026